It seems a bit odd that we haven’t heard much about amantadine (Gocovri, Symadine, and Symmetrel) in chronic fatigue syndrome (ME/CFS) or long COVID
Side effects can include insomnia and vivid dreams
They also noted the clinically significant improvement from baseline in the mean MFIS total score for all treatments Article Highlight: Fatigue is one of the most common problems among patients living with multiple sclerosis (MS)
The NICE guidelines concluded that the efficacy of any pharmacological agents specifically to treat neurological fatigue is yet to be established
Since fatigue cannot be characterized by a single symptom or behavior, a variety of neuropsychological, behavioral, and self-report measures were used to monitor changes across different Fatigue is considered to be one of the main causes of impaired quality of life among MS patients, independent of depression or disability
The NICE guidelines concluded that the efficacy of any pharmacological agents specifically to treat neurological fatigue is yet to be established
Amantadine was the first therapy that showed efficacy, albeit modest, for treatment of fatigue in patients with MS
Prescribing medicines used to relieve fatigue from diseases such as cancer and multiple sclerosis are another recommended solution for post-COVID-19 fatigue 25
Your doctor may increase your dose to 274 mg (two 137 mg capsules) once a day at bedtime after one week
In current practice, both pharmacological and non-pharmacological interventions are used
Background: Fatigue is a common complication associated with multiple sclerosis (MS)
When assessing a person with MS-related fatigue, the first step is to rule out potential triggers or causes of fatigue, which may be related to MS, such as urinary Satisfaction